Global Non-Anticogulant Rodenticide Market, By Type (Bromethalin, Cholecalciferol, Strychnine, Zinc Phosphide), Mode of Application (Pellet, Spray, Blocks, Powder), Rodent Type (Rats, Hamsters, Chipmunks, Mouse, Others), End Use (Agricultural Field, Warehouses, Pest Control Companies, Urban Centers, Residential, Commercial), Country (U.S., Canada, Mexico, Germany, Poland, Ireland, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, New Zealand, Vietnam, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Chile, Rest of South America, UAE, Saudi Arabia, Egypt, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2028
Market Analysis and Insights: Global Non-Anticoagulant Rodenticide Market
The non-anticoagulant rodenticide market is likely to reach USD 0.69 billion by 2028 and is expected to expand at a compound annual growth rate of 4.80% over the forecast period of 2021 to 2028. The availability of natural rodenticides is the factor for the non-anticogulant rodenticide market in the forecast period of 2021 to 2028.
Rodenticides are usually used for the killing and resist the rodents from the areas prone to damage by the rats and similar animals in residential spaces, commercial settings, agricultural land fields and warehouses.
The non-anticogulant rodenticide market is expected to gain growth, due to the rise in damages due to rodent attacks. Also the displacement of rodents due to urbanization and rapid technological advancements are also expected to drive the market for non-anticogulant rodenticide over the forecast period of 2021 to 2028. The impact of climatic changes on rodent proliferation and rise in concerns regarding vector-based disease outbreaks encourage public health initiatives are also likely to lift the growth of the non-anticogulant rodenticide market. Also the increase in prevalence of pest-related diseases and high demand for pest control are also the major driving factors leading towards the growth of the non-anticogulant rodenticide market.
However, the strict regulations and the ban on the use of rodenticides in developed countries and rise in the use of mechanical methods for rodent control are expected to curb the growth of the non-anticogulant rodenticide market in the above mentioned forecast period, whereas the high toxicity of rodenticides and rise in resistance to conventional rodenticides can challenge the growth of the target market.
In addition, the rapid rise in government initiatives and support of public corporations for rodent control and high demand for rodent pest control services from the hospitality and tourism sectors are expected to accelerate various growth opportunities that will enhance the growth of the non-anticoagulant rodenticide market in the forecast period of 2021 to 2028.
This non-anticogulant rodenticide market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the non-anticoagulant rodenticide market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Non-Anticogulant Rodenticide Market Scope and Market Size
The non-anticoagulant rodenticide market is segmented on the basis of type, mode of application, rodent type and end use. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
- On the basis of type, the non-anticogulant rodenticide market is segmented into bromethalin, cholecalciferol, strychnine and zinc phosphide.
- Based on mode of application, the non-anticogulant rodenticide market is segmented into pellet, spray, blocks and powder.
- On the basis of rodent type, the non-anticogulant rodenticide market is segmented into rats, hamsters, chipmunks, mouse and others. Others have further been segmented into voles and gerbils.
The non-anticogulant rodenticide market is also segmented on the basis of end use into agricultural field, warehouses, pest control companies, urban centers, residential and commercial.
Non-Anticogulant Rodenticide Market Country Level Analysis
The non-anticoagulant rodenticide market is analyses and market size, volume information is provided by country, type, mode of application, rodent type and end use as referenced above.
The countries covered in the non-anticoagulant rodenticide market report are U.S., Canada, Mexico in North America, Germany, Poland, Ireland, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe in Europe, Japan, China, India, South Korea, New Zealand, Vietnam, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), Brazil, Argentina, Chile, Rest of South America as a part of South America, U.A.E, Saudi Arabia, Egypt, Kuwait, South Africa, Rest of Middle East and Africa(MEA) as a part of Middle East and Africa(MEA).
North America leads the non-anticogulant rodenticide market because of the strong presence of a large number of manufacturers, associated with high standards of hygiene. Asia-Pacific is expected to expand at a significant growth rate over the forecast period of 2021 to 2028 because of the rapid rise in the population.
The country section of the non-anticogulant rodenticide market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Non-Anticogulant Rodenticide Market Share Analysis
The non-anticoagulant rodenticide market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to non-anticogulant rodenticide market.
The major players covered in the non-anticogulant rodenticide report are BASF SE, Bayer AG, Syngenta, UPL, Liphatech, Inc., JT Eaton, NEOGEN CORPORATION, Pelgar International, Rentokil Initial Plc, SenesTech, Inc., Anticimex, Bell Labs, Abell Group of Companies, Impex Europa S.L., Rollins, Inc., The Terminix International Company Limited, Ecolab, Truly Nolen of America, Inc., Futura GmbH and Bioguard Pest Solutions among other domestic and global players. Market share data is available for Global, North America, Europe, Asia Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-